Study shows vaccine rapidly protects against lethal Lassa fever

Canada News News

Study shows vaccine rapidly protects against lethal Lassa fever
Canada Latest News,Canada Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 51%

Study shows vaccine rapidly protects against lethal Lassafever utmb_news CellReports

Dr. Robert Cross, one of the lead researchers on the study, said the single injection vaccine elicited protection against observable disease in 100 percent of subjects when administered seven days prior to exposure and prevented serious disease with full recovery in 100 percent of subjects vaccinated three days prior to exposure.

"While Lassa is endemic in West Africa, imported cases have occurred in both Europe and the United States as a result of commercial air travel. Besides Dengue, Lassa Fever is the viral hemorrhagicthat is most often exported by travel to other parts of the world. This is possibly due to a long incubation period," said Dr. Courtney Woolsey, co-lead author of the study.

Lassa virus is an acute viral infection that originates and spreads through contact with a common African rat. Symptoms typically appear one to three weeks after exposure. While the majority of infections are mild or even asymptomatic, in 20 percent of cases the disease can progress to more serious symptoms including hemorrhaging, severe respiratory distress, repeated vomiting, facial swelling, pain in the chest, back, and abdomen, and shock.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Study results encourage SARS-CoV-2–infected mothers breastfeed to protect infants from COVIDStudy results encourage SARS-CoV-2–infected mothers breastfeed to protect infants from COVIDStudy results encourage SARS-CoV-2–infected mothers breastfeed to protect infants from COVID Antibodies ChildHealth Coronavirus Disease COVID SARSCoV2 breastmilk cordblood newborn pregnant glycoprotein
Read more »

Study finds widespread false memories of logos and characters, including Mr. Monopoly and PikachuStudy finds widespread false memories of logos and characters, including Mr. Monopoly and PikachuIf you had to describe Rich Uncle Pennybags—the Monopoly mascot—would you mention his top hat? His mustache? How about his monocle?
Read more »

Study shows that older adults can generate robust, long-lived memory against SARS-CoV-2 following infectionStudy shows that older adults can generate robust, long-lived memory against SARS-CoV-2 following infectionStudy shows that older adults can generate robust, long-lived memory against SARS-CoV-2 following infection SARSCoV2 infection COVID19 coronavirus covid immunity HSN_Sudbury thenosm UConn LancetLongevity
Read more »

Study suggests COVID-19 vaccination may be associated with short-term changes in usual menstrual cycle lengthStudy suggests COVID-19 vaccination may be associated with short-term changes in usual menstrual cycle lengthStudy suggests COVID-19 vaccination may be associated with short-term changes in usual menstrual cycle length HarvardChanSPH michiganstateu harvardmed BrighamWomens vaccine vaccination COVID19 coronavirus covid menstrualcycle menstruation
Read more »

The potential of circular RNA COVID-19 vaccinesThe potential of circular RNA COVID-19 vaccinesThe potential of circular RNA COVID-19 vaccines Coronavirus Disease COVID RNA circularRNA mRNAvaccines WileyHealth
Read more »



Render Time: 2025-03-26 14:53:16